infirst HEALTHCARE Appoints Dr Viv Edwards as Director of Regulatory and Medical Affairs
London, 16 September 2013 - infirst HEALTHCARE, the consumer healthcare company focused on improving well-established drugs, announced today the appointment of Dr Viv Edwards to the newly created position of Director of Regulatory and Medical Affairs.
Dr Edwards has over 15 years’ experience in product registration across the respiratory, gastrointestinal, musculoskeletal and women's health categories and will be responsible for regulatory affairs at infirst HEALTHCARE. She joins the company from Procter & Gamble where she worked in the Consumer Healthcare and Pharmaceuticals divisions.
Manfred Scheske, Chief Executive Officer of infirst HEALTHCARE, said: “We are delighted to welcome Viv to our team. Her exceptional experience in the regulatory field will be crucial to the business as we prepare our first products for market. Furthermore, Viv shares our passion to make a real difference to people’s lives by making known drugs better.”
infirst HEALTHCARE is focused on bringing innovation to well-known medicines and improving the treatment options available. Its first products aim to improve treatments for the management of inflammatory pain, as well as cough and cold conditions.
For all media enquiries, please contact:
Nicky Blunt – Good Relations Brand Communications
E: email@example.com / t: 020 7861 3107
About infirst HEALTHCARE
infirst HEALTHCARE is a new consumer healthcare company focused on improving well established drugs with IP protected solutions for the OTC/Primary care markets which can be launched within 12-36 months. infirst is a spin-out from SEEK, a UK privately-owned drug discovery group which uses its intellectual property to create breakthrough medicines addressing major diseases, bringing radical improvements to human health.
infirst is led by CEO, Manfred Scheske, who was previously President of GSK’s US$3 billion European Consumer Healthcare business (including brands such as alli, Aquafresh, Beechams, Corsodyl, Lucozade, Niquitin, Panadol, Piriton, Poligrip, Ribena, Sensodyne, Solpadeine, Zantac and Zovirax) from 2004 to 2010 and also spent six years as President of GSK’s Consumer Healthcare business in North America.
5th floor, Holborn Gate,
26 Southampton Buildings,
London WC2A 1PQ
Tel: +44 (0)20 78613134
Mob: +44 (0)7900913549
Posted: September 2013